Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Axim Biotechnologies (AXIM)

Axim Biotechnologies (AXIM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AXIM with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4911 +31.34%
on 04/16/21
0.7700 -16.23%
on 04/16/21
-0.0250 (-3.73%)
since 03/16/21
3-Month
0.3940 +63.71%
on 02/01/21
0.9440 -31.67%
on 02/10/21
+0.1730 (+36.65%)
since 01/15/21
52-Week
0.1201 +437.05%
on 04/27/20
1.4400 -55.21%
on 07/16/20
+0.4850 (+303.13%)
since 04/16/20

Most Recent Stories

More News
AXIM(R) Biotechnologies' Manufacturing Partner Empowered Diagnostics Files Emergency Use Authorization With FDA for Use of Its Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that...

AXIM : 0.6450 (+12.66%)
AXIM(R) Biotechnologies Successfully Completes Point-of-Care Clinical Trials on its Rapid COVID-19 Neutralizing Antibody Test

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that...

AXIM : 0.6450 (+12.66%)
AXIM(R) Biotechnologies Begins Clinical Trials on Its ImmunoPass Rapid Diagnostic Test With Vaccine Recipients

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today the...

AXIM : 0.6450 (+12.66%)
AXIM(R) Biotechnologies Issues Update Letter to Shareholders

AXIM Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that it...

AXIM : 0.6450 (+12.66%)
Medical Marijuana, Inc. Investment Company AXIM(R) Biotechnologies Files Patent for World's First Face Mask Designed to Capture SARS-CoV-2 (COVID-19)

via NewMediaWire -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical...

MJNA : 0.0433 (-7.87%)
AXIM : 0.6450 (+12.66%)
AXIM(R) Biotechnologies Files Patent for World's First Face Mask Designed to Capture SARS-CoV-2 COVID-19

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that...

AXIM : 0.6450 (+12.66%)
AXIM(R) Biotechnologies Receives Notice of U.S. Patent Allowance for Proprietary Compounds and Methods Targeting Tumor Metastasis Through QSOX1

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that...

AXIM : 0.6450 (+12.66%)
AXIM(R) Biotechnologies Files Emergency Use Authorization With the FDA for First-in-Class COVID-19 Rapid Diagnostic Test for Neutralizing Antibodies

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today it has...

AXIM : 0.6450 (+12.66%)
AXIM(R) Biotechnologies Signs Exclusive Licensing, Manufacturing and Distribution Agreement for High Volume Production of the COVID-19 Rapid Neutralizing Antibody Test

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that...

AXIM : 0.6450 (+12.66%)
Sapphire Biotech, Subsidiary of AXIM(R) Biotechnologies, Awarded Prestigious Phase I Small Business Innovation Research Grant by National Cancer Institute

AXIM(R) Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM(R) Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announces that its wholly-owned...

AXIM : 0.6450 (+12.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 1.0585
2nd Resistance Point 0.9143
1st Resistance Point 0.7796
Last Price 0.6450
1st Support Level 0.5007
2nd Support Level 0.3565
3rd Support Level 0.2218

See More

52-Week High 1.4400
Fibonacci 61.8% 0.9358
Fibonacci 50% 0.7801
Last Price 0.6450
Fibonacci 38.2% 0.6243
52-Week Low 0.1201

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar